MS-3203

A 42-year-old female with uncontrolled rheumatoid arthritis and a history of extensive large bowel surgery is prescribed sulfasalazine, a prodrug. However, the consultant is concerned that her shortened colon may hinder the conversion of the prodrug into its active form.

What is the name of the therapeutically active compound that sulfasalazine is converted to in the colon?